> Diabetes Research > Stem Cell Therapy for Diabetics

Stem Cell Therapy for Diabetics

Stem cell Therapy generally refers to any treatment strategy in which new adult stem cells are introduced or injected into a damaged or impaired tissue, which will initiate the regeneration or reproduction of new cells that will replace infected or damaged cells resulting to treatment. This fundamentally rests on the ability of stem cells to self-renew and replace the damaged tissues in the body, with marginal risk of rejection or negative side effects. Stem cell therapy is widely accepted to be effective for bone marrow transplantation and is commonly used for skin rejuvenation. Thus, stem cell therapy is more renowned for aesthetic treatment to counter the signs of aging like wrinkles and other skin damages. In the case of bone marrow transplants, the stem cells used normally come from the patient themselves or from human donors. There are some instances when animal cells are used.

Stem Cell researchers are looking forward of the potential of the therapy for treating deadly and incurable diseases such as cancer, Parkinson’s disease, neurological disorders as well as Diabetes. The effectiveness and application of the therapy for such diseases are still undergoing scientific investigation to ascertain their validity. In the case of stem cell treatment for Diabetes, the principal idea is to protect, replenish and propagate the beta cells in the pancreas which is primarily responsible for producing insulin, which controls glucose levels in the blood. Healthy embryonic stem beta cells may be culturally developed then injected in a diabetic patient, which will stimulated to the creation of beta cells and replace the dysfunctional ß cells. Theoretically, the idea is very much practicable. However, this hasn’t been successfully tested and validated by medical science. As of the moment, some challenges the researchers are faced included the proliferation, differentiation, survival and integration of the transplanted cells in the deficient cells and in the host.

Hope should not be lost however. A recent medical breakthrough from the University of Illinois at Chicago released early on 2012 demonstrated how stem cell therapy can effectively combat diabetes using immobilized cord blood stem cells (CBSC) from healthy donors. The C-peptide protein fragment in the autoimmune control interceded by the autoimmune regulator in the CBSC which facilitated the recovery of beta cells that in turn allow it to regenerate healthy insulin producing beta cells.

Related terms:

Related Posts:

» Tags: , , ,

Related terms:

Leave a Reply

Your email address will not be published. Required fields are marked *